サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1754291

ディスポシリンジ（使い捨て注射器）の世界市場 - 市場規模、シェア、動向、予測：製品タイプ別、用途別、エンドユーザー別、地域別、2025年～2033年

Disposable Syringes Market Size, Share, Trends and Forecast by Product Type, Application, End User, and Region, 2025-2033

出版日
発行
IMARC
ページ情報
英文 145 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.69円
ディスポシリンジ（使い捨て注射器）の世界市場 - 市場規模、シェア、動向、予測：製品タイプ別、用途別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ディスポシリンジ（使い捨て注射器）の世界市場規模は2024年に161億1,000万米ドルとなりました。今後、IMARC Groupは、2033年には288億9,000万米ドルに達し、2025年から2033年にかけて6.37%のCAGRを示すと予測しています。現在、北米が市場を独占しており、2024年には41.6％を超える大きな市場シェアを占めています。北米のディスポシリンジ市場シェアは、ワクチン需要の増加、慢性疾患の流行、医療投資の増加といった要因によって牽引されています。さらに、感染管理、安全規制、無針注射システムの採用に対する意識の高まりが、同地域における市場の成長と技術革新に寄与しています。

糖尿病、がん、心血管疾患などの慢性疾患の増加により、注射薬やインスリンの需要が高まっており、ディスポシリンジが必要とされています。さらに、清潔さと感染回避に関する国際的な関心の高まりにより、交差汚染や針刺し損傷を最小限に抑えるためにディスポシリンジへのシフトが進んでいます。政府や医療機関もより厳格な安全ガイドラインを採用し、医療従事者と患者の両方を守るためにディスポシリンジの使用を奨励しています。さらに、特にCOVID-19パンデミックによるワクチン需要の増加が、集団予防接種用のディスポシリンジの需要を加速させています。自動無効化シリンジやプレフィルドシリンジの開発など、技術の進歩は患者の安全性と使いやすさを向上させ、ディスポシリンジ市場の成長とともに技術革新を促しています。

米国は、高度な医療インフラ、イノベーション、規制基準などの要因によって、主要な市場破壊者として際立っています。同国は医療に重点を置いており、糖尿病、心血管疾患、がんなどの慢性疾患の有病率が高いため、注射薬の需要が高く、ディスポシリンジの使用を促しています。米国では、特にCOVID-19パンデミックの間、ワクチン供給が国の活動の中心となっており、集団ワクチン接種を促進するディスポシリンジの需要をさらに押し上げています。さらに米国は、プレフィルドシリンジ、自動無効化シリンジ、無針シリンジの設計など、医療機器イノベーションの先陣を切っています。FDAのような、より厳格な規制環境は、シリンジ業界における安全性と技術革新のレベルの向上を要求しています。さらに、米国では遠隔医療や在宅医療サービスが大量に利用されるようになり、ディスポシリンジのニーズも高まっています。

ディスポシリンジ市場の動向：

安全設計シリンジに対する需要の高まり

ディスポシリンジ市場では、針刺し傷害を最小限に抑え、感染症の伝播を減少させる必要性から、安全設計シリンジの需要が増加しています。これらのシリンジには、使用後に注射針を自動的に収納またはカバーする安全機構が搭載されており、医療従事者と患者の両方の保護が強化されています。病院や診療所では、特に救急医療のようなリスクの高い環境で、これらのシリンジの採用が増加しています。安全プロトコルに対する意識の高まりと医療規制の厳格化が相まって、安全設計ディスポシリンジ市場は拡大し、業界の成長を支え、医療全体の安全基準の向上に貢献しています。最近では、Hindustan Syringes and Medical Devices（HMD）が安全針を装備したディスポシリンジDispojektを発表し、医療機器の世界的リーダーとしてのインドの役割を高めています。

シリンジ設計の技術的進歩

シリンジ設計の革新はディスポシリンジ市場の主要動向です。メーカー各社は、シリンジの性能、使いやすさ、患者の快適性を高めるために新技術を導入しています。重要な進歩の一つはプレフィルドシリンジの開発であり、ワクチン、生物製剤、注射薬にますます好まれるようになっています。プレフィルドシリンジは投与ミスのリスクを低減し、ドラッグデリバリーの効率を高め、一貫した正確な投与量を確保します。これらのシリンジはまた、特に糖尿病などの慢性疾患のために、自宅で薬剤を自己投与する傾向の高まりに対応し、高度な使い捨てシリンジソリューションの需要を押し上げています。最近、薬剤封じ込めとドラッグデリバリーのソリューションを提供するドイツのSCHOTT Pharma社は、安全性と効率の向上を目指した次世代システムSCHOTT TOPPAC infuseポリマーシリンジを発表しました。一方、インドのIITボンベイ校の研究者らは、衝撃波を利用した無針シリンジを開発し、安全で痛みのない薬剤投与を実現するとともに、皮膚へのダメージを最小限に抑え、感染リスクを低減しました。これらの開発は、ディスポシリンジ市場をさらに活性化させています。

ワクチン投与での使用拡大

ディスポシリンジ市場は、特にCOVID-19パンデミック後のワクチン需要の増加により、近年大きな成長を遂げています。ディスポシリンジは、その無菌性、安全性、利便性により、ワクチン投与に広く使用されています。政府および医療機関はワクチン接種キャンペーンを強化しており、特に大規模な予防接種活動において、シリンジの大幅なニーズを生み出しています。世界の予防接種プログラムの継続的な推進により、ディスポシリンジは公衆衛生の目標達成に不可欠なものとなっています。この動向は今後も続くと予想され、シリンジ生産への継続的な投資により、世界中で拡大する予防接種のニーズを満たす安定供給が確保されます。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のディスポシリンジ市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 従来型シリンジ
  • 安全シリンジ
    • 主要セグメント
      • 格納式安全シリンジ
      • 非格納式安全シリンジ

第7章 市場内訳：用途別

  • 予防注射
  • 治療

第8章 市場内訳：エンドユーザー別

  • 病院
  • 診断検査室
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Cardinal Health Inc.
    • Fresenius SE & Co. KGaA
    • Henke-Sass Wolf GmbH
    • Nipro Corporation
    • Novo Nordisk A/S
    • Retractable Technologies Inc.
    • Terumo Corporation
    • Vita Needle Company
図表

List of Figures

  • Figure 1: Global: Disposable Syringes Market: Major Drivers and Challenges
  • Figure 2: Global: Disposable Syringes Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Disposable Syringes Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Disposable Syringes Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Disposable Syringes Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Disposable Syringes Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Disposable Syringes Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Disposable Syringes (Conventional Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Disposable Syringes (Conventional Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Disposable Syringes (Safety Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Disposable Syringes (Safety Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Disposable Syringes (Immunization Injections) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Disposable Syringes (Immunization Injections) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Disposable Syringes (Therapeutic Injections) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Disposable Syringes (Therapeutic Injections) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Disposable Syringes (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Disposable Syringes (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Disposable Syringes (Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Disposable Syringes (Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Disposable Syringes (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Disposable Syringes (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: North America: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: North America: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: United States: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: United States: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Canada: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Canada: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Asia-Pacific: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Asia-Pacific: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: China: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: China: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Japan: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Japan: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: India: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: India: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: South Korea: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: South Korea: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Australia: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Australia: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Indonesia: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Indonesia: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Others: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Others: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Europe: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Europe: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Germany: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Germany: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: France: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: France: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: United Kingdom: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: United Kingdom: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Italy: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Italy: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Spain: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Spain: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Russia: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Russia: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Latin America: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Latin America: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Brazil: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Brazil: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Mexico: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Mexico: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Middle East and Africa: Disposable Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Middle East and Africa: Disposable Syringes Market: Breakup by Country (in %), 2024
  • Figure 70: Middle East and Africa: Disposable Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Global: Disposable Syringes Industry: SWOT Analysis
  • Figure 72: Global: Disposable Syringes Industry: Value Chain Analysis
  • Figure 73: Global: Disposable Syringes Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Disposable Syringes Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Disposable Syringes Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Disposable Syringes Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Disposable Syringes Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Disposable Syringes Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Disposable Syringes Market: Competitive Structure
  • Table 7: Global: Disposable Syringes Market: Key Players
目次
Product Code: SR112025A5753

The global disposable syringes market size was valued at USD 16.11 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 28.89 Billion by 2033, exhibiting a CAGR of 6.37% during 2025-2033. North America currently dominates the market, holding a significant market share of over 41.6% in 2024. The North American disposable syringes market share is driven by factors such as the growing demand for vaccines, increasing chronic disease prevalence, and rising healthcare investments. Additionally, heightened awareness about infection control, safety regulations, and the adoption of needleless injection systems contribute to the market's growth and innovation in the region.

The growing incidence of chronic diseases like diabetes, cancer, and cardiovascular diseases has made injectable medications and insulin in greater demand, necessitating disposable syringes. Additionally, the growing international concern regarding cleanliness and infection avoidance has resulted in a shift toward single-use syringes for minimizing cross-contamination and needle-stick injury. Governments and healthcare institutions are also adopting stricter safety guidelines, encouraging the use of disposable syringes to safeguard both healthcare professionals and patients. Furthermore, increased demand for vaccines, especially due to the COVID-19 pandemic, has speeded up the demand for disposable syringes for mass immunizations. Technological advancements, including the creation of auto-disable syringes and pre-filled syringes, are improving patient safety and usability, encouraging innovation along with disposable syringes market growth.

The United States stands out as a key market disruptor, driven by factors such as advanced healthcare infrastructure, innovation, and regulatory standards. The nation's robust emphasis on healthcare coupled with its high prevalence of chronic conditions such as diabetes, cardiovascular diseases, and cancer has fueled high demand for injectable drugs, hence inducing use of disposable syringes. Vaccine delivery in the US is also at the center of the country's activity, especially during the COVID-19 pandemic, further boosting demand for disposable syringes to facilitate mass vaccination. Further, the US is in the vanguard of medical device innovation, such as in the design of pre-filled syringes, auto-disable syringes, and needle-free injectors. More stringent regulatory environments, such as in the form of the FDA, have required increased levels of safety and innovation within the syringe industry. In addition, the mass use of telemedicine and home healthcare services in the US has also increased the need for disposable syringes, further increasing market disruption.

Disposable Syringes Market Trends:

Increasing demand for safety-engineered syringes

The disposable syringes market is witnessing a growing demand for safety-engineered syringes, driven by the need to minimize needle-stick injuries and reduce the transmission of infectious diseases. These syringes are equipped with safety mechanisms that automatically retract or cover the needle after use, enhancing protection for both healthcare workers and patients. Hospitals and clinics are increasingly adopting these syringes, particularly in high-risk environments like emergency care settings. The rising awareness about safety protocols, combined with stricter healthcare regulations, has led to an expansion in the market for safety-engineered disposable syringes, supporting industry growth and contributing to the improvement of overall healthcare safety standards. Recently, Hindustan Syringes and Medical Devices (HMD) introduced Dispojekt single-use syringes equipped with safety needles, enhancing India's role as a global leader in medical devices.

Technological advancements in syringe design

Innovation in syringe design is a key trend in the disposable syringes market. Manufacturers are incorporating new technologies to enhance syringe performance, ease of use, and patient comfort. One significant advancement is the development of prefilled syringes, which are increasingly preferred for vaccines, biologics, and injectable drugs. Prefilled syringes reduce the risk of dosing errors, improve the efficiency of drug delivery, and ensure a consistent and accurate dose. These syringes also cater to the growing trend of at-home self-administration of medications, especially for chronic conditions such as diabetes, boosting the demand for advanced disposable syringe solutions. Recently, SCHOTT Pharma, a German supplier of drug containment and delivery solutions, introduced the next generation of SCHOTT TOPPAC infuse polymer syringes, a system aimed at enhancing safety and efficiency. In the meantime, researchers at IIT Bombay in India have created a needle-free syringe that uses shockwaves, ensuring safe and painless drug administration while minimizing skin damage and reducing the risk of infection. These developments further continue to fuel the market for disposable syringes.

Growing usage in vaccine administration

The disposable syringes market has experienced significant growth in recent years due to the increased demand for vaccines, especially following the COVID-19 pandemic. Disposable syringes are widely used for vaccine delivery due to their sterility, safety, and convenience. Governments and healthcare organizations are ramping up vaccination campaigns, creating a substantial need for syringes, particularly in large-scale immunization efforts. With the continued global push for vaccination programs, disposable syringes are integral to meeting public health goals. This trend is expected to persist, with continuous investments in syringe production, ensuring a steady supply to meet the growing needs of vaccination drives worldwide.

Disposable Syringes Industry Segmentation:

Analysis by Product Type:

  • Conventional Syringes
  • Safety Syringes
    • Retractable Safety Syringes
    • Non-Retractable Safety Syringes

Safety syringes stand as the largest component in 2024, holding around 80.9% of the market. Safety syringes represent a major segment of the disposable syringes market, fueled by the growing need for improved safety features in healthcare environments. Safety syringes are intended to minimize the risk of needle-stick injuries, which can result in the transmission of infectious diseases like HIV, hepatitis, and other bloodborne pathogens. Safety syringes usually have an intrinsic safety mechanism that protects the needle after being used, providing safety to healthcare workers during and after injections. With increasing need for healthcare worker safety and patient health, usage of safety syringes has increased, especially in hospitals, clinics, and other healthcare facilities. Regulatory agencies like the FDA and OSHA have also tightened safety standards, further prompting the use of safety syringes. Increased needle-stick injuries, as well as growing rates of chronic diseases that necessitate repeated injections, have boosted this segment, making safety syringes an integral component of the disposable syringes market.

Analysis by Application:

  • Immunization Injections
  • Therapeutic Injections

Therapeutic injections lead the market with around 75.1% of market share in 2024. Therapeutic injections account for a major portion of the application segment within the disposable syringes market, fueled by the growing demand for injectable drugs in numerous therapeutic categories. Therapeutic injections are frequently employed for the management of chronic diseases like diabetes, arthritis, cancer, and cardiovascular diseases, which tend to need long-term medication administration. Diabetes management through insulin injections is a key driver in this segment, with the global incidence of diabetes still on the increase. Biologic therapies, such as monoclonal antibodies and other high-value drugs, also depend significantly on injectable formulations, further increasing demand for disposable syringes. The convenience, ease of use, and precision offered by disposable syringes in delivering therapeutic injections make them a critical instrument in healthcare facilities. In addition, the increasing popularity of home-based healthcare and self-injectors, along with emerging trends in pre-filled syringes, has favored the growth of therapeutic injections as a vital application segment in the disposable syringes market outlook.

Analysis by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Others

Hospitals leads the market with around 43.7% of market share in 2024. Hospitals form a major segment of the end-user market in disposable syringes due to the demand for safe, efficient, and sterile injection techniques in healthcare. The large patient volume and varied treatment needs in hospitals make them core users of disposable syringes for a range of medical procedures, such as injections, blood withdrawal, and administration of anesthesia. The frequency of high doses of medications given in hospitals, especially for long-term illnesses like diabetes, cancer, and infectious diseases, makes the extensive use of disposable syringes inevitable. Furthermore, hospitals ensure safety to avoid needle-stick injuries and the spread of infection, and this results in the increased use of safety syringes and auto-disable syringes. As hospitals are confronting increasing patient volumes and growing emphasis on infection prevention and patient safety, demand for disposable syringes is projected to keep growing. In addition, the trend toward the use of advanced healthcare technologies, including pre-filled syringes and injectable biologics, continues to grow the demand for disposable syringes in the hospital environment.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 41.6%. North America is the leading region for the disposable syringes market, with support from developed healthcare infrastructure, immense healthcare expenditure, and a large incidence of chronic diseases. The United States holds the position of the largest market in this region, with significant demand for disposable syringes supported by widespread injectable medication use for conditions like diabetes, cardiovascular diseases, and cancer. Moreover, the region's well-established healthcare system of hospitals, clinics, and outpatient facilities requires constant use of disposable syringes for procedures such as vaccinations, blood extraction, and therapeutic injections. Increasing emphasis on safety and prevention of needle-stick injury has further promoted the usage of safety syringes in North America. Regulatory authorities such as the FDA also take a key role in maintaining stringent standards of quality and safety in syringes. In addition, the developing trend towards home healthcare and home injection treatments is fueling the demand for North American disposable syringes.

Key Regional Takeaways:

United States Disposable Syringes Market Analysis

In 2024, the United States accounted for over 93.30% of the disposable syringes market in North America. The growth of the disposable syringes market in the United States is significantly influenced by the high prevalence of chronic diseases. An estimated 129 Million people in the U.S. suffer from at least one major chronic condition, such as heart disease, cancer, diabetes, obesity, or hypertension, as defined by the U.S. Department of Health and Human Services. This growing burden of chronic diseases fuels the demand for injectable treatments, driving the need for disposable syringes. Alongside this, advancements in healthcare infrastructure and a shift toward injectable biologics further contribute to market expansion. The increasing focus on hygiene and safety, along with measures to prevent needle-stick injuries, strengthens demand. Government initiatives, such as needle exchange programs and the push for eco-friendly products, further bolster growth. The COVID-19 pandemic also accelerated syringe demand due to mass vaccination efforts. With a rise in home healthcare, where patients self-administer injections, disposable syringes offer convenience and safety, pushing the market forward. Innovations in syringe design, such as safety-engineered and self-destructive syringes, enhance user safety and support continued market growth. Increased outpatient treatments and surgeries also contribute to the higher demand for disposable syringes.

Asia Pacific Disposable Syringes Market Analysis

The disposable syringes market in the Asia-Pacific (APAC) region is propelled by rapid urbanization, rising healthcare spending, and an aging population. According to reports, the number of older persons in Asia and the Pacific is projected to more than double, from 630 Million in 2020 to approximately 1.3 Billion by 2050, further increasing the demand for injectable treatments. Additionally, the cancer incidence in Asia, as reported, was 169.1 per 100,000 in 2020, accounting for 49.3% of global cancer cases, with lung, breast, and colorectal cancers being the most prevalent. These factors drive the need for syringes, as injectable therapies are increasingly utilized in cancer treatment and other chronic conditions. The growing preference for self-administered medications also boosts market demand, with disposable syringes offering convenience and safety. Expanding healthcare infrastructure in developing nations, such as India and China, and government initiatives to improve healthcare standards further support the market's growth in the region.

Europe Disposable Syringes Market Analysis

The disposable syringes market in Europe is primarily driven by the growing incidence of chronic diseases, especially diabetes, and an aging population. According to reports, as of January 1, 2023, the EU population was estimated at 448.8 Million, with more than one-fifth (21.3%) aged 65 years and over. This demographic shift increases the demand for injectable treatments, as the elderly are more prone to chronic conditions that require ongoing medical intervention. The rise in injectable biologics and biosimilars further boosts the market for disposable syringes, which are favored for their safety, affordability, and ease of use. Stringent regulatory frameworks in the region ensure the availability of high-quality products, bolstering consumer trust. Technological innovations, such as retractable and safety-engineered syringes, enhance user safety and contribute to market growth. The increasing number of surgeries, outpatient care services, and vaccination campaigns, particularly during health crises like the COVID-19 pandemic, further support demand. Additionally, Europe's growing focus on sustainable and eco-friendly medical products aligns with the demand for environmentally conscious disposable syringes. The increasing trend toward home healthcare services, where disposable syringes are widely used for self-administration, is also expected to drive market expansion in the region.

Latin America Disposable Syringes Market Analysis

The disposable syringes market in Latin America is driven by the rising prevalence of chronic diseases, which are expected to cause 928,000 deaths annually in Brazil alone, underscoring the growing demand for injectable treatments, including stem cell therapies. The expansion of healthcare access and increasing healthcare expenditure, particularly in countries like Brazil and Mexico, further fuels market growth. Government initiatives to improve healthcare infrastructure and promote awareness are key growth factors. The adoption of injectable therapies and biologics continues to support the increasing demand for disposable syringes across the region.

Middle East and Africa Disposable Syringes Market Analysis

In the Middle East and Africa, the disposable syringes market is influenced by the prevalence of chronic diseases, with 23% of the population in the UAE reporting such conditions. Obesity (12.5%), diabetes (4.2%), and asthma/allergies (3.2%) are among the most common. This growing burden of chronic diseases contributes to the increased need for injectable treatments. Along with healthcare infrastructure improvements, the rising demand for vaccinations and self-administered medications further supports the market. Technological advancements in syringe design and government efforts to improve healthcare access are key drivers of market expansion in the region.

Competitive Landscape:

Several leading companies in the disposable syringes market are aggressively pursuing growth through various strategic initiatives on innovation, safety, and geographic expansion. Top players are heavily investing in research and development to design sophisticated products like safety syringes, pre-filled syringes, and auto-disable syringes that go a long way in ensuring safety and ease of injection procedures. These syringes have safety mechanisms against needle-stick injuries, which tackle key healthcare issues in infection control. To address increasing demand for injectable drugs, especially for long-term conditions such as diabetes, industry stakeholders are also concentrating on creating affordable, high-quality solutions that suit healthcare professionals and patients alike. Further, collaborations with pharmaceutical firms to manufacture specialized syringes for particular drugs, including biologics and vaccines, are also on the rise. Scaling up production capacities and enhancing distribution networks to make disposable syringes widely available, particularly in the emerging markets, is another priority area. Additionally, strategic partnerships with healthcare institutions and adherence to strict regulatory standards, including those of the FDA and WHO, guarantee product safety and quality.

The report provides a comprehensive analysis of the competitive landscape in the disposable syringes market with detailed profiles of all major companies, including:

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Cardinal Health Inc.
  • Fresenius SE & Co. KGaA
  • Henke-Sass Wolf GmbH
  • Nipro Corporation
  • Novo Nordisk A/S
  • Retractable Technologies Inc.
  • Terumo Corporation
  • Vita Needle Company

Key Questions Answered in This Report

  • 1.How big is the disposable syringes market?
  • 2.What is the future outlook of disposable syringes market?
  • 3.What are the key factors driving the disposable syringes market?
  • 4.Which region accounts for the largest disposable syringes market share?
  • 5.Which are the leading companies in the global disposable syringes market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Disposable Syringes Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Conventional Syringes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Safety Syringes
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Retractable Safety Syringes
      • 6.2.2.2 Non-Retractable Safety Syringes
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Immunization Injections
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Therapeutic Injections
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 B. Braun Melsungen AG
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Baxter International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Becton Dickinson and Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Cardinal Health Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Fresenius SE & Co. KGaA
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Henke-Sass Wolf GmbH
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Nipro Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Novo Nordisk A/S
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Retractable Technologies Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Terumo Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Vita Needle Company
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio